Skip to content

Use of Benzodiazepines and Z Drugs in the Elderly

Assessment of Problematic Use of Benzodiazepines and Z Drugs in the Elderly in France: a Public Health Issue

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01920581
Enrollment
1100
Registered
2013-08-12
Start date
2012-02-29
Completion date
2014-02-28
Last updated
2013-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Benzodiazepines and Related Drugs Users

Keywords

CEIP, pharmacodependance, addictovigilance, benzodiazepines and benzodiazepines related drugs, elderly

Brief summary

The aim of this study is to evaluate benzodiazepines and related drugs (zolpidem and zopiclone) usage in an outpatient population of chronic users over 65 years in France using a questionnaire assessing substance dependence according to DSM-IV (Diagnostic and Statistical Manual of mental disorders) international standards.

Detailed description

1100 patients will be recruited by pharmacists. They will answer to a standardized questionnaire assessing their benzodiazepines or related drugs usage (phone contact). Pharmacists are recruited by all French Centers For Evaluation and Information on Pharmacodependence (CEIP).

Interventions

None listed

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 65 years old or more, * benzodiazepines or benzodiazepines related drugs treatment for at least three months, * written consent and without

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frame
Dependence according to DSM IV criteria2 years

Secondary

MeasureTime frame
withdrawal syndrome2 years
psychiatric comorbidities2 years
Dependence scores2 years

Countries

France

Contacts

Primary ContactPascale Jolliet, PUPH
pascale.jolliet@chu-nantes.fr33 2.40.08.40.96
Backup ContactCaroline Vigneau, PH
caroline.vigneau@chu-nantes.fr33 2.40.08.40.73

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026